drugset / Trial / NCT04411901

The Role of Vitamin D3 in Pediatric Bronchiectasis Severity

NCT04411901

Phase 2/3 Completed 40 enrolled Heba Omara
NaSingle-groupOpen-labelTreatment

Summary

Vitamin D3 therapy was effective in decreasing the frequency of pulmonary exacerbations and preserving lung functions , thereby improving the disease severity even more in non CF than CF bronchiectasis patients

Timeline

Start
2018-03-01
Primary completion
2018-09-06
Completion
2019-03-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified Oral

Indications